AVREEO

Cardiovascular pharmaceuticals; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine and the musculo-skeletal system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology and in rheumatology; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; all the aforesaid goods to be available upon prescription only, not for over-the-counter sale, and none of them for topical administration

Medical devices, namely, medical devices for diagnosing or treating respiratory conditions, medical devices for facilitating the inhalation of pharmaceutical preparations; injection devices for medical use, namely, injection devices for pharmaceuticals, injection devices for administering drugs; autoinjectors in the nature of injection devices for the administration of pharmaceutical preparations